Derivation of the clinical grade human embryonic stem cell line RCe020-a (RC-16)

Stem Cell Res. 2016 May;16(3):790-4. doi: 10.1016/j.scr.2016.04.002. Epub 2016 Apr 9.

Abstract

The human embryonic stem cell line RCe020-A (RC-16) was derived under quality assured compliance with UK regulation, European Union Directives and International guidance for tissue procurement, processing and storage according to Good Manufacturing Practice (GMP) standards. The cell line was derived from a failed to fertilise oocyte voluntarily donated as unsuitable or surplus to fertility requirements following informed consent. RCe020-A (RC-16) shows normal pluripotency marker expression and differentiates to mesoderm and potentially ectoderm in vitro. It has an abnormal 47XX, +14, i(20)(q10) female karyotype and microsatellite PCR identity, HLA and blood group typing data is available.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blastocyst / cytology*
  • Blood Group Antigens / metabolism
  • Cell Differentiation
  • Cells, Cultured
  • Cellular Reprogramming
  • Female
  • Genotype
  • Histocompatibility Testing
  • Human Embryonic Stem Cells / cytology*
  • Human Embryonic Stem Cells / metabolism
  • Humans
  • Karyotype
  • Microsatellite Repeats / genetics
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Blood Group Antigens
  • Transcription Factors